Altimmune, Inc. (ALT) Tops Q2 EPS by 3c

Altimmune, Inc. (NASDAQ: ALT) reported Q2 EPS of ($0.12), $0.03 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• Google execs convened 'all-hands' meeting last week to address AI unit reorganizations amid staff concerns - Reuters
• Canada weighs accepting US auto tariffs for lower rates on compliant vehicles
• CFRA Downgrades 3M (MMM) to Buy